These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1457227)

  • 1. The last few days.
    Enck RE
    Am J Hosp Palliat Care; 1992; 9(4):11-3. PubMed ID: 1457227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
    Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
    BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal restlessness--its management and the role of midazolam.
    Burke AL; Diamond PL; Hulbert J; Yeatman J; Farr EA
    Med J Aust; 1991 Oct; 155(7):485-7. PubMed ID: 1921821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sedation in the terminal phase of life].
    Verhagen EH; Eliel MR; de Graeff A; Teunissen SC
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2601-3. PubMed ID: 10633803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Palliative sedation].
    Verhagen EH; Hesselmann GM; Besse TC; de Graeff A
    Ned Tijdschr Geneeskd; 2005 Feb; 149(9):458-61. PubMed ID: 15771339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous midazolam infusion in palliative care.
    Bottomley DM; Hanks GW
    J Pain Symptom Manage; 1990 Aug; 5(4):259-61. PubMed ID: 2384705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
    Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
    JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care.
    Bleasel MD; Peterson GM; Dunne PF
    Palliat Med; 1994; 8(3):231-6. PubMed ID: 7952373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer.
    Ramani S; Karnad AB
    South Med J; 1996 Nov; 89(11):1101-3. PubMed ID: 8903298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care.
    Berger JM; Ryan A; Vadivelu N; Merriam P; Rever L; Harrison P
    Am J Hosp Palliat Care; 2000; 17(2):127-34. PubMed ID: 11406957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled sedation for refractory symptoms in dying patients.
    Mercadante S; Intravaia G; Villari P; Ferrera P; David F; Casuccio A
    J Pain Symptom Manage; 2009 May; 37(5):771-9. PubMed ID: 19041216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative sedation in patients with advanced cancer followed at home: a prospective study.
    Mercadante S; Porzio G; Valle A; Aielli F; Casuccio A;
    J Pain Symptom Manage; 2014 May; 47(5):860-6. PubMed ID: 24099896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
    DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
    Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ketamine, fentanyl, and midazolam infusion for uncontrolled terminal pain and agitation.
    Enck RE
    Am J Hosp Palliat Care; 2000; 17(2):76-7. PubMed ID: 11406960
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of midazolam and haloperidol in cancer patients at the end of life.
    Radha Krishna LK; Poulose VJ; Goh C
    Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients.
    Fainsinger RL; Waller A; Bercovici M; Bengtson K; Landman W; Hosking M; Nunez-Olarte JM; deMoissac D
    Palliat Med; 2000 Jul; 14(4):257-65. PubMed ID: 10974977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Palliative sedation at a university palliative care unit--a descriptive analysis].
    Hopprich A; Günther LD; Laufenberg-Feldmann R; Reinholz U; Weber M
    Dtsch Med Wochenschr; 2016 Apr; 141(8):e60-6. PubMed ID: 27078251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and use of benzodiazepines in a palliative care unit].
    Stiel S; Krumm N; Schroers O; Radbruch L; Elsner F
    Schmerz; 2008 Dec; 22(6):665-71. PubMed ID: 18612660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing patterns of the four most commonly used sedatives in endoscopic examination in Korea: propofol, midazolam, diazepam, and lorazepam.
    Shin JY; Lee SH; Shin SM; Kim MH; Park SG; Park BJ
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):565-70. PubMed ID: 25659208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom prevalence and control during cancer patients' last days of life.
    Ventafridda V; Ripamonti C; De Conno F; Tamburini M; Cassileth BR
    J Palliat Care; 1990; 6(3):7-11. PubMed ID: 1700099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.